biote Corp. (BTMD) vs Spectral AI, Inc. (MDAI)
A side-by-side comparison of biote Corp. and Spectral AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BTMD
biote Corp.
$1.19HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT
MDAI
Spectral AI, Inc.
$1.70HealthcareDelayed quote: Oct 6, 2026, 12:05 PM EDT
Total return — BTMD vs MDAI
growth of $100 · dividends reinvested · last 5yBTMD -88.9% (-35.5%/yr)MDAI -82.7% (-29.6%/yr)MDAI compounded faster over this window
BTMD MDAI
BTMD vs MDAI: by the numbers
- •MDAI is the larger company ($54M vs $52M market cap).
- •BTMD is profitable (3.19% net margin) while MDAI runs a net loss (-69.27%).
Metrics side by side
Valuation
| Metric | BTMD | MDAI |
|---|---|---|
| P/E ratio | 10.20 | N/A |
| P/S ratio | 0.29 | 3.57 |
| EV / EBITDA | 9.14 | N/A |
| FCF yield | 37.50% | N/A |
Profitability
| Metric | BTMD | MDAI |
|---|---|---|
| Gross margin | 71.46% | 41.51% |
| Operating margin | 18.50% | -43.78% |
| Net margin | 3.19% | -69.27% |
| ROIC | 13.63% | -353.68% |
Growth (annualized)
| Metric | BTMD | MDAI |
|---|---|---|
| Revenue CAGR (5Y) | 10.52% | N/A |
| EPS CAGR (5Y) | -25.90% | N/A |
| FCF CAGR (5Y) | 3.81% | N/A |
| Total return CAGR (5Y) | -35.12% | -29.57% |
Frequently asked
- Is BTMD or MDAI more profitable?
- BTMD runs the higher net margin — BTMD at 3.19% versus MDAI at -69.27%.
- How have BTMD and MDAI total returns compared?
- Over the past 5 years, BTMD delivered -35.12% and MDAI delivered -29.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
biote P/E ratiobiote ROESpectral AI ROEbiote operating marginSpectral AI operating marginbiote revenue growthSpectral AI revenue growthbiote free cash flowSpectral AI free cash flow
biote & Spectral AI appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.